e-Drug3D 623 |
cas 82410-32-0 |
CLASS ANTIINFECTIVES |
ROUTE (list) INJECTION ORAL IMPLANTATION OPHTHALMIC INTRAVENOUS |
PK parameters Tmax 2 HOUR Solubility APPROXIMATELY 6 MILLIGRAM / MILLILITER AT 37 DEGREE CELSIUS |
Target TARGET THYMIDINE KINASE PDB Ligand code = GA2 (link to the list of PDB complexes) Download experimental 3D coordinates of GA2 with added hydrogens |
DrugCentral DNA polymerase catalytic subunit UNIPROT P04293 |
Download SDF file | 2-amino-9-(1,3-dihydroxypropan-2-yloxymethyl)-3H-purin-6-one Formula: Calculated chemical properties: MW 255.24 NB_atoms 18 XLogP -1.97 PSA 128.967 NB_HD 5 NB_HA 9 fsp3 0.44 Lipinski(0=no;1=yes) 1 |
FDA NDA 076457 (pdf not found) INN (GANCICLOVIR) GANCICLOVIR (RANBAXY LABS LTD) APPROVAL= - YEAR= 0 DISCONTINUED NDA 019661 (pdf not found) INN (GANCICLOVIR SODIUM) CYTOVENE (CHEPLAPHARM) APPROVAL= AP YEAR= 1989 DISCONTINUED NDA 020460 (pdf not found) INN (GANCICLOVIR) CYTOVENE (ROCHE PALO) APPROVAL= AP YEAR= 1994 DISCONTINUED NDA 020569 (pdf not found) INN (GANCICLOVIR) VITRASERT (BAUSCH AND LOMB) APPROVAL= AP YEAR= 1996 DISCONTINUED NDA 076222 (pdf not found) INN (GANCICLOVIR SODIUM) GANCICLOVIR SODIUM (HIKMA) APPROVAL= AP YEAR= 2003 NDA 022211 (pdf not found) INN (GANCICLOVIR) ZIRGAN (BAUSCH AND LOMB) APPROVAL= AP YEAR= 2009 NDA 090658 (pdf not found) INN (GANCICLOVIR SODIUM) GANCICLOVIR SODIUM (FRESENIUS KABI USA) APPROVAL= AP YEAR= 2010 NDA 202624 (pdf not found) INN (GANCICLOVIR SODIUM) GANCICLOVIR SODIUM (AM REGENT) APPROVAL= AP YEAR= 2013 DISCONTINUED NDA 204950 (pdf not found) INN (GANCICLOVIR SODIUM) GANCICLOVIR SODIUM (PH HEALTH) APPROVAL= AP YEAR= 2016 NDA 209347 (pdf not found) INN (GANCICLOVIR) GANZYK-RTU (EXELA PHARMA) APPROVAL= AP YEAR= 2017 DISCONTINUED NDA 204560 (pdf not found) INN (GANCICLOVIR SODIUM) GANCICLOVIR SODIUM (ONESOURCE SPECIALTY) APPROVAL= AP YEAR= 2017 DISCONTINUED NDA 207645 (pdf not found) INN (GANCICLOVIR SODIUM) GANCICLOVIR SODIUM (PHARMASCIENCE INC) APPROVAL= AP YEAR= 2017 NDA 204204 (pdf not found) INN (GANCICLOVIR SODIUM) GANCICLOVIR SODIUM (SLATE RUN PHARMA) APPROVAL= AP YEAR= 2018 NDA 212001 (pdf not found) INN (GANCICLOVIR SODIUM) GANCICLOVIR SODIUM (CUSTOPHARM INC) APPROVAL= AP YEAR= 2019 DISCONTINUED |
Other links: |